Tema Neuroscience and Mental Health ETF Rating $23.31 -0.06 (-0.25%) Closing price 08/1/2025 12:46 PM EasternExtended Trading$23.31 0.00 (0.00%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Neuroscience and Mental Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MNTL Aggregate RatingModerate Buy 2.83Holdings in MNTL have an aggregate rating of Moderate Buy based on 606 analyst ratings issued in the past year covering 39 companies (93.0% of the portfolio).MNTL Aggregate Price Target$23.31High Prediction$23.31Average Prediction$23.31Low Prediction$23.31Holdings in MNTL have an aggregate price target of $23.31 and a range of $23.31 to $23.31 covering 39 companies (93.0% of the portfolio).MNTL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Neuroscience and Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 MNTL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.43%VRTXVertex Pharmaceuticals$462.13+1.2%4.341 of 5 stars2.50$509.89 10.3%26Positive NewsUpcoming EarningsShort Interest ↑8.10%REGNRegeneron Pharmaceuticals$558.87+2.5%4.9072 of 5 stars2.75$828.86 48.3%24Trending NewsAnalyst ForecastGap Up6.49%ALNYAlnylam Pharmaceuticals$401.80+2.4%3.8767 of 5 stars2.81$392.13 -2.4%26Trending NewsAnalyst Forecast5.02%NBIXNeurocrine Biosciences$128.91+0.5%4.6866 of 5 stars2.86$160.90 24.8%22Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision4.89%TEVATeva Pharmaceutical Industries$15.38-0.5%3.979 of 5 stars3.25$24.71 60.7%8News CoveragePositive NewsEarnings ReportGap Up4.82%ARGXargenex$673.80+0.5%2.8337 of 5 stars3.10$736.81 9.4%21Trending NewsEarnings ReportAnalyst Forecast4.23%LLYEli Lilly and Company$761.47+2.9%4.9083 of 5 stars2.75$1,012.56 33.0%20Trending NewsUpcoming Earnings3.82%CRNXCrinetics Pharmaceuticals$27.84-2.6%3.3086 of 5 stars2.80$69.50 149.6%10News CoverageUpcoming Earnings3.60%IONSIonis Pharmaceuticals$43.03+0.1%4.5202 of 5 stars2.86$59.38 38.0%14Trending NewsEarnings ReportAnalyst ForecastInsider Trade3.41%SYKStryker$378.62-3.6%4.9251 of 5 stars2.79$429.35 13.4%19Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading Volume3.31%BIIBBiogen$131.95+3.1%4.8467 of 5 stars2.34$185.63 40.7%32Trending NewsEarnings ReportAnalyst ForecastHigh Trading Volume2.61%MDTMedtronic$89.31-1.0%4.5574 of 5 stars2.59$98.19 9.9%22Positive News2.42%CPRXCatalyst Pharmaceuticals$21.12-1.0%4.8963 of 5 stars3.25$32.83 55.5%8Positive NewsUpcoming Earnings2.40%AXSMAxsome Therapeutics$103.02+1.6%4.8236 of 5 stars3.06$172.33 67.3%16Positive NewsUpcoming Earnings2.25%DNLIDenali Therapeutics$13.44-2.8%4.5689 of 5 stars3.12$33.85 151.8%17News CoverageUpcoming Earnings2.24%ACADACADIA Pharmaceuticals$23.53-1.3%3.988 of 5 stars2.71$28.13 19.5%17News CoverageUpcoming EarningsAnalyst Revision2.03%XENEXenon Pharmaceuticals$30.50-0.1%3.016 of 5 stars3.00$54.82 79.7%12News CoveragePositive NewsShort Interest ↑1.85%DXCMDexCom$79.28-1.8%4.9726 of 5 stars2.90$99.89 26.0%21Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision1.83%JAZZJazz Pharmaceuticals$115.52+0.8%4.8563 of 5 stars2.93$181.64 57.2%14Positive NewsUpcoming Earnings1.71%ALKSAlkermes$26.55+0.2%4.7551 of 5 stars2.83$41.08 54.7%12Earnings ReportAnalyst ForecastAnalyst Revision1.71%SRRKScholar Rock$36.36-1.9%3.7908 of 5 stars3.22$44.14 21.4%9News CoveragePositive NewsUpcoming EarningsAnalyst Forecast1.57%RNAAvidity Biosciences$35.92-2.2%2.7576 of 5 stars3.06$66.35 84.7%17News CoverageUpcoming Earnings1.53%OPCHOption Care Health$28.26-3.7%4.6323 of 5 stars2.89$35.75 26.5%9News CoveragePositive NewsEarnings ReportAnalyst Forecast1.53%PTCTPTC Therapeutics$52.13+0.0%4.482 of 5 stars2.67$69.38 33.1%15Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision1.53%PENPenumbra$242.50-3.9%4.6111 of 5 stars2.94$300.47 23.9%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.04%DAWNDay One Biopharmaceuticals$6.65-0.9%2.2503 of 5 stars3.14$29.00 336.1%7Upcoming Earnings0.98%IMVTImmunovant$15.71-2.3%1.4287 of 5 stars2.82$36.40 131.7%11Positive NewsUpcoming Earnings0.82%NTLAIntellia Therapeutics$11.49-1.3%4.499 of 5 stars2.65$33.37 190.4%20News CoverageUpcoming EarningsGap Down0.73%TALKTalkspace$2.31-4.9%3.5557 of 5 stars3.00$4.50 94.8%7Upcoming Earnings0.60%ACHCAcadia Healthcare$21.09-3.1%4.1024 of 5 stars2.60$47.94 127.3%10Upcoming Earnings0.56%BHVNBiohaven$14.77-2.2%2.3513 of 5 stars3.07$58.46 295.8%15Trending NewsUpcoming Earnings0.49%PRAXPraxis Precision Medicines$54.09-0.2%2.4074 of 5 stars2.78$94.11 74.0%9Analyst Forecast0.48%VYGRVoyager Therapeutics$2.96-7.2%4.1076 of 5 stars3.13$13.39 352.4%8Upcoming Earnings0.42%SLDBSolid Biosciences$6.83-0.1%2.6433 of 5 stars3.17$15.10 121.1%12Gap Down0.42%DYNDyne Therapeutics$10.05+2.0%3.572 of 5 stars3.00$36.25 260.7%17Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision0.40%PRTAProthena$6.81-0.9%3.0877 of 5 stars2.33$31.50 362.6%9News CoverageUpcoming Earnings0.35%SRPTSarepta Therapeutics$15.91-3.1%4.7 of 5 stars2.10$49.12 208.7%29Trending NewsUpcoming EarningsAnalyst ForecastOptions Volume0.18%RAPPRapport Therapeutics$14.15-1.5%1.1907 of 5 stars3.00$28.00 97.9%10.16%ARVNArvinas$7.42-0.3%3.4676 of 5 stars2.55$20.29 173.4%22News CoverageUpcoming Earnings This page (NASDAQ:MNTL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNTL Stock Alerts